Reckitt Benckiser Successfully Completes Tender Offer for Shares of Schiff Nutrition

  Reckitt Benckiser Successfully Completes Tender Offer for Shares of Schiff
                                  Nutrition

PR Newswire

SLOUGH, England, Dec. 17, 2012

SLOUGH, England, Dec. 17, 2012 /PRNewswire/ --Reckitt Benckiser Group plc
("Reckitt Benckiser" or "RB") (LSE: RBL) announced today the successful
completion of the tender offer (the "Offer") made by Reckitt Benckiser's
indirect wholly-owned subsidiary Ascot Acquisition Corp. for all of the
outstanding shares of Class A common stock and Class B common stock of Schiff
Nutrition International, Inc. ("Schiff Nutrition") (NYSE: SHF) at a purchase
price of $42.00 per share, net to the seller in cash, without interest, less
any applicable withholding taxes as specified in the Offer to Purchase filed
by Ascot Acquisition Corp. with the Securities and Exchange Commission on
November 27, 2012. The Offer expired at 11:59 p.m., New York City time, on
Friday, December 14, 2012.

According to the final report of the depositary for the Offer, as of the
expiration of the Offer, a total of 28,745,180 shares of Schiff Nutrition
common stock were validly tendered and not withdrawn prior to the expiration
of the Offer, which represent approximately 96.266% of all outstanding shares
of Schiff Nutrition common stock and 90.137% of all outstanding shares of
Schiff Nutrition common stock on a fully-diluted basis. In addition, 397,714
shares of Schiff Nutrition common stock have been delivered pursuant to the
guaranteed delivery procedures. The aggregate number of shares validly
tendered and not properly withdrawn pursuant to the Offer exceeds the "minimum
condition" and, accordingly, Ascot Acquisition Corp. accepted for payment all
such shares in accordance with the terms of the Offer and will promptly pay
for such shares in accordance with the terms of the Offer.

In accordance with that certain Agreement and Plan of Merger, dated as of
November 21, 2012 (the "Merger Agreement"), by and among the Schiff Nutrition,
Reckitt Benckiser LLC, Ascot Acquisition Corp. and, solely for the purposes
specified in the Merger Agreement, Reckitt Benckiser, following consummation
of the Offer, Ascot Acquisition Corp. intends to effect a "short-form" merger
under applicable Delaware law, at which time Schiff Nutrition will become an
indirect wholly owned subsidiary of Reckitt Benckiser. All outstanding shares
of common stock of Schiff Nutrition, other than shares held by Schiff
Nutrition, Reckitt Benckiser LLC, Ascot Acquisition Corp. or any of their
respective wholly-owned subsidiaries, or by Schiff Nutrition stockholders who
are entitled to and properly exercise appraisal rights under Delaware law,
will be canceled and converted into the right to receive cash equal to the
$42.00 Offer price per share, net in cash, without interest, less any
applicable withholding taxes. In addition, upon completion of the merger, the
Class A common stock of Schiff Nutrition will cease to be traded on the NYSE.

Forward-Looking Statements

Statements herein regarding the proposed transaction between Reckitt Benckiser
and Schiff, future financial and operating results and any other statements
about future expectations constitute "forward looking statements." These
forward looking statements may be identified by words such as "believe,"
"expects," "anticipates," "projects," "intends," "should," "estimates" or
similar expressions. Such statements are based upon current beliefs and
expectations and are subject to significant risks and uncertainties. There
are a number of important factors that could cause actual results or events to
differ materially from those indicated by such forward looking statements. We
believe these forward-looking statements are reasonable; however, undue
reliance should not be placed on any forward-looking statements, which are
based on current expectations. All written and oral forward-looking statements
attributable to us or persons acting on our behalf are qualified in their
entirety by these cautionary statements. Further, forward-looking statements
speak only as of the date they are made, and we undertake no obligation to
update or revise forward-looking statements to reflect changed assumptions,
the occurrence of unanticipated events or changes to future operating results
over time unless required by law.

Investor & Analyst Contacts:

Reckitt Benckiser (RB)
United Kingdom
Richard Joyce
Director, Investor Relations
+44 1753 217800

Media Contacts:
United States
Sard Verbinnen & Co (+1 212 687-8080)
Jim Barron
Jared Levy
Brooke Gordon

United Kingdom
Reckitt Benckiser (RB)
Andraea Dawson-Shepherd
SVP, Global Corporate Communication & Affairs
+44 1753 446447

SOURCE Reckitt Benckiser Group plc